Anti-GAD65 autoantibody levels measured by ELISA and alternative types of immunoassays in relation to neuropsychiatric diseases versus diabetes mellitus type 1

Anti-GAD65 autoantibody levels measured by ELISA and alternative types of immunoassays in relation to neuropsychiatric diseases versus diabetes mellitus type 1

BackgroundAnti-GAD65 autoantibodies (GAD65-Abs) may occur in patients with epilepsy and other neurological disorders, but the clinical significance is not clear-cut. Whereas high levels of GAD65-Abs are considered pathogenic in neuropsychiatric disorders, low or moderate levels are only considered a...

Full description

Bibliographic Details
Main Authors: Shenghua Zong, Anita M. Vinke, Peng Du, Carolin Hoffmann, Marina Mané-Damas, Peter C. Molenaar, Jan G. M. C. Damoiseaux, Mario Losen, Rob P. W. Rouhl, Pilar Martinez-Martinez
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Neurology
Subjects:
GAD65 autoantibodies
autoimmune encephalitis
epilepsy
diabetes type 1
neuronal autoantibodies
ELISA
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1111063/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2023.1111063/full

Similar Items